Investment
Features
FeesSafety
Academy
More
Pluang+

Compare HCA Health Inc (HCA) vs Banco Santander SA (SAN) Price & Performance

HCA Health IncTrade
Banco Santander SATrade

Price performance (Past 24H)

Key statistics

HCA Health Inc vs Banco Santander SA — how do they compare? HCA Health Inc trades at $372.1 (market cap $82.17B), while Banco Santander SA trades at $13.52 (market cap $191.46B). The key difference: Banco Santander SA is far larger — about 2.3× HCA Health Inc's market cap, and Banco Santander SA pays the higher dividend (2.09%). Which is the better fit depends on your goals.

HCASAN
Market Cap
$82.17B$191.46B
Sector
HealthFinancials
52-Week High
$545.13$14.37
52-Week Low
$334.32$8.40
Enterprise Value
$131.08B
Dividend Yield
0.84%2.09%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

HCA Health Inc

HCA Healthcare trades at $370.74, down 0.12% on the day, with a bearish technical signal but strong fundamentals including consistent earnings beats and revenue growth to $75.6 billion in 2025. The stock faces headwinds from lowered 2026 guidance and negative news flow, but maintains a solid valuation with a P/E of 12.79 and positive analyst consensus.

The outlook is mixed: attractive valuation and operational strength support upside to the $469.40 price target, but near-term risks from payer mix shifts and legal investigations warrant caution. Long-term growth drivers include capacity expansion and medical advancements, though investor sentiment is currently pressured.

Banco Santander SA

Banco Santander (SAN) trades at $13.31, down 1.77% on the day, with a neutral technical signal and mixed earnings history. The company reported Q1 2026 EPS of $0.41, beating expectations, but missed in prior quarters. Revenue for 2025 was $60.02B with a net income margin of 26.72%. Recent news highlights Santander's AI initiatives, acquisition of Webster Bank, and becoming Spain's most valuable company. Cash flow trends show operational challenges, with net cash flow negative in recent years.

Outlook is cautiously optimistic with a 64% analyst buy rating, targeting efficiency gains and AI-driven value. Risks include regulatory probes, declining cash flows, and high debt levels. The stock offers a dividend yield with the recent $0.15 payout, but investors should weigh operational improvements against financial volatility and macroeconomic pressures in the banking sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About HCA Health Inc

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.

Read more on HCA

About Banco Santander SA

Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.

Read more on SAN